A Double blind, Randomized, 2-Period Crossover Study to Compare the Tolerance and Safety of Sustained Release Formulation Quetiapine Fumarate (SEROQUEL) with Placebo in Healthy Volunteers

Study identifier:D1448C00008

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Double blind, Randomized, 2-Period Crossover Study to Compare the Tolerance and Safety of Sustained Release Formulation Quetiapine Fumarate (SEROQUEL) with Placebo in Healthy Volunteers

Medical condition

schizophrenia

Phase

Phase 1

Healthy volunteers

-

Study drug

-

Sex

-

Actual Enrollment

-

Study type

Interventional

Age

-

Date

Study Start Date: 01 May 2005
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

-

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria